Acadian Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-103,179
| Closed | -$1.17M | – | 1869 |
|
|
2024
Q1 | $1.17M | Sell |
103,179
-152,746
| -60% | -$1.73M | ﹤0.01% | 802 |
|
|
2023
Q4 | $3.59M | Sell |
255,925
-236,956
| -48% | -$3.32M | 0.01% | 536 |
|
|
2023
Q3 | $6.09M | Sell |
492,881
-86,428
| -15% | -$1.07M | 0.03% | 384 |
|
|
2023
Q2 | $5.23M | Buy |
579,309
+3,409
| +0.6% | +$30.8K | 0.02% | 449 |
|
|
2023
Q1 | $2M | Hold |
575,900
| – | – | 0.01% | 715 |
|
|
2022
Q4 | $1.41M | Buy |
575,900
+2,923
| +0.5% | +$7.15K | 0.01% | 761 |
|
|
2022
Q3 | $1.58M | Buy |
572,977
+106,811
| +23% | +$295K | 0.01% | 695 |
|
|
2022
Q2 | $1.9M | Buy |
466,166
+351,090
| +305% | +$1.43M | 0.01% | 649 |
|
|
2022
Q1 | $489K | Buy |
115,076
+14,454
| +14% | +$61.4K | ﹤0.01% | 1007 |
|
|
2021
Q4 | $940K | Buy |
+100,622
| New | +$940K | ﹤0.01% | 850 |
|